triggered drug release
Recently Published Documents


TOTAL DOCUMENTS

339
(FIVE YEARS 93)

H-INDEX

49
(FIVE YEARS 9)

2022 ◽  
pp. 237-264
Author(s):  
Rajesh Salve ◽  
Pramod Kumar ◽  
Kavita R. Gajbhiye ◽  
Rajnigandha A. Shende ◽  
Bhushan P. Chaudhari ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (20) ◽  
pp. 5146
Author(s):  
Marjolein I. Priester ◽  
Sergio Curto ◽  
Ann L. B. Seynhaeve ◽  
Anderson Cruz Perdomo ◽  
Mohamadreza Amin ◽  
...  

This paper presents three devices suitable for the preclinical application of hyperthermia via the simultaneous high-resolution imaging of intratumoral events. (Pre)clinical studies have confirmed that the tumor micro-environment is sensitive to the application of local mild hyperthermia. Therefore, heating is a promising adjuvant to aid the efficacy of radiotherapy or chemotherapy. More so, the application of mild hyperthermia is a useful stimulus for triggered drug release from heat-sensitive nanocarriers. The response of thermosensitive nanoparticles to hyperthermia and ensuing intratumoral kinetics are considerably complex in both space and time. To obtain better insight into intratumoral processes, longitudinal imaging (preferable in high spatial and temporal resolution) is highly informative. Our devices are based on (i) an external electric heating adaptor for the dorsal skinfold model, (ii) targeted radiofrequency application, and (iii) a microwave antenna for heating of internal tumors. These models, while of some technical complexity, significantly add to the understanding of effects of mild hyperthermia warranting implementation in research on hyperthermia.


2021 ◽  
pp. 2100159
Author(s):  
Emilia M. Zywot ◽  
Natalia Orlova ◽  
Song Ding ◽  
Rishi R. Rampersad ◽  
Emily M. Rabjohns ◽  
...  

Pharmaceutics ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1396
Author(s):  
Muhammad Umair Amin ◽  
Sajid Ali ◽  
Imran Tariq ◽  
Muhammad Yasir Ali ◽  
Shashank Reddy Pinnapreddy ◽  
...  

The immediate release of chemotherapeutics at the target site, along with no premature release in circulation is always challenging. The purpose of this study was to develop a stimuli responsive drug delivery system, composed of lipid supported mesoporous silica nanoparticles (MSNPs) for triggered drug release at the target site and simultaneously avoiding the premature release. MSNPs with a higher drug loading capacity and very slow release were designed so as to enhance release by FDA approved US-irradiation. Doxorubicin, as a model drug, and perfluoropentane (PFP) as a US responsive material, were entrapped in the porous structure of MSNPs. Lipid coating enhanced the cellular uptake and in addition provided a gatekeeping effect at the pore opening to reduce premature release. The mechanical and thermal effects of US induced the conversion of liquid PFP to a gaseous form that was able to rupture the lipid layer, resulting in triggered drug release. The prolonged stability profile and non-toxic behavior made them suitable candidate for the delivery of anticancer drugs. This smart system, with the abilities of better cellular uptake and higher cytotoxic effects on US-irradiation, would be a good addition to the applied side of chemotherapeutic advanced drug delivery systems.


Sign in / Sign up

Export Citation Format

Share Document